Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2006-12-12
pubmed:abstractText
Acrylamide (ACR) is a conjugated type-2 alkene that produces synaptic toxicity presumably by sulfhydryl adduction. The alpha,beta-unsaturated carbonyl of ACR is a soft electrophile and, therefore, adduction of nucleophilic thiol groups could occur through a conjugate (Michael) addition reaction. To address the mechanism of thiol adduct formation and corresponding neurotoxicological importance, we defined structure-toxicity relationships among a series of conjugated type-2 alkenes (1 microM-10mM), which included acrolein and methylvinyl ketone. Results show that exposure of rat striatal synaptosomes to these chemicals produced parallel, concentration-dependent neurotoxic effects that were correlated to loss of free sulfhydryl groups. Although differences in relative potency were evident, all conjugated analogs tested were equiefficacious with respect to maximal neurotoxicity achieved. In contrast, nonconjugated alkene or aldehyde congeners did not cause synaptosomal dysfunction or sulfhydryl loss. Acrolein and other alpha,beta-unsaturated carbonyls are bifunctional (electrophilic reactivity at the C-1 and C-3 positions) and could produce in vitro neurotoxicity by forming protein cross-links rather than thiol monoadducts. Immunoblot analysis detected slower migrating, presumably derivatized, synaptosomal proteins only at very high acrolein concentrations (>or= 25 mM). Exposure of synaptosomes to high concentrations of ACR (1M), N-ethylmaleimide (10mM), and methyl vinyl ketone (MVK) (100mM) did not alter the gel migration of synaptosomal proteins. Furthermore, hydralazine (1mM), which blocks the formation of protein cross-links, did not affect in vitro acrolein neurotoxicity. Thus, type-2-conjugated alkenes produced synaptosomal toxicity that was linked to a loss of thiol content. This is consistent with our hypothesis that the mechanism of ACR neurotoxicity involves formation of Michael adducts with protein sulfhydryl groups.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/3-buten-2-one, http://linkedlifedata.com/resource/pubmed/chemical/Acrolein, http://linkedlifedata.com/resource/pubmed/chemical/Acrylamide, http://linkedlifedata.com/resource/pubmed/chemical/Acrylates, http://linkedlifedata.com/resource/pubmed/chemical/Aldehydes, http://linkedlifedata.com/resource/pubmed/chemical/Alkenes, http://linkedlifedata.com/resource/pubmed/chemical/Allyl Compounds, http://linkedlifedata.com/resource/pubmed/chemical/Butanones, http://linkedlifedata.com/resource/pubmed/chemical/Cross-Linking Reagents, http://linkedlifedata.com/resource/pubmed/chemical/Ethylmaleimide, http://linkedlifedata.com/resource/pubmed/chemical/Hydralazine, http://linkedlifedata.com/resource/pubmed/chemical/Membrane Fusion Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Propanols, http://linkedlifedata.com/resource/pubmed/chemical/Sulfhydryl Compounds, http://linkedlifedata.com/resource/pubmed/chemical/Sulfhydryl Reagents, http://linkedlifedata.com/resource/pubmed/chemical/allyl alcohol, http://linkedlifedata.com/resource/pubmed/chemical/allyl chloride, http://linkedlifedata.com/resource/pubmed/chemical/methyl acrylate, http://linkedlifedata.com/resource/pubmed/chemical/propionaldehyde
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
1096-6080
pubmed:author
pubmed:issnType
Print
pubmed:volume
95
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
136-46
pubmed:dateRevised
2010-9-17
pubmed:meshHeading
pubmed-meshheading:17023561-Acrolein, pubmed-meshheading:17023561-Acrylamide, pubmed-meshheading:17023561-Acrylates, pubmed-meshheading:17023561-Aldehydes, pubmed-meshheading:17023561-Alkenes, pubmed-meshheading:17023561-Allyl Compounds, pubmed-meshheading:17023561-Animals, pubmed-meshheading:17023561-Blotting, Western, pubmed-meshheading:17023561-Brain, pubmed-meshheading:17023561-Butanones, pubmed-meshheading:17023561-Cross-Linking Reagents, pubmed-meshheading:17023561-Dopamine, pubmed-meshheading:17023561-Dose-Response Relationship, Drug, pubmed-meshheading:17023561-Ethylmaleimide, pubmed-meshheading:17023561-Hydralazine, pubmed-meshheading:17023561-Male, pubmed-meshheading:17023561-Membrane Fusion Proteins, pubmed-meshheading:17023561-Neurons, pubmed-meshheading:17023561-Propanols, pubmed-meshheading:17023561-Rats, pubmed-meshheading:17023561-Rats, Sprague-Dawley, pubmed-meshheading:17023561-Structure-Activity Relationship, pubmed-meshheading:17023561-Sulfhydryl Compounds, pubmed-meshheading:17023561-Sulfhydryl Reagents, pubmed-meshheading:17023561-Synaptic Vesicles, pubmed-meshheading:17023561-Synaptosomes, pubmed-meshheading:17023561-Tandem Mass Spectrometry
pubmed:year
2007
pubmed:articleTitle
Structure-toxicity analysis of type-2 alkenes: in vitro neurotoxicity.
pubmed:affiliation
Department of Anesthesiology, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York 10467, USA. lopachin@aecom.yu.edu
pubmed:publicationType
Journal Article, In Vitro, Research Support, N.I.H., Extramural